HCC screening: assessment of an abbreviated non-contrast MRI protocol.
Michael Vinchill ChanStephen J McDonaldYang-Yi OngKaterina MastrocostasEdwin HoYa Ruth HuoCositha SanthakumarAlice Unah LeeJessica YangPublished in: European radiology experimental (2019)
Our aNC-MRI HCC screening protocol demonstrated high specificity (93%) and NPV (97%), with a sensitivity (85%) comparable to that of ultrasound and gadoxetic acid contrast-enhanced MRI. This screening method was robust to hepatic steatosis and may be considered an alternative in the case of suboptimal ultrasound image quality.